Hyperuricemia in Asian psoriatic arthritis patients

It is generally accepted that hyperuricemia is commonly associated with psoriatic arthritis (PsA). However, variations in ethnicity, diet and habitat may contribute to differences in prevalence and risk factors for hyperuricemia in PsA patients. Moreover, Asian specific data is deficient. The primary objective of the present study was to determine the prevalence of hyperuricemia among PsA patients. The secondary objective was to explore its associated risk factors.

[1]  Y. Narisawa,et al.  Hyperuricemia is an independent risk factor for psoriatic arthritis in psoriatic patients , 2017, The Journal of dermatology.

[2]  B. Li,et al.  Association of Serum Uric Acid Levels in Psoriasis , 2016, Medicine.

[3]  M. Doherty,et al.  Global epidemiology of gout: prevalence, incidence and risk factors , 2015, Nature Reviews Rheumatology.

[4]  G. Ji,et al.  Association of Serum Uric Acid with Body Mass Index: A Cross-Sectional Study from Jiangsu Province, China , 2014, Iranian journal of public health.

[5]  P. Gisondi.  Hyperuricemia in Patients with Chronic Plaque Psoriasis , 2014, Drug development research.

[6]  A. Qureshi,et al.  Psoriasis, psoriatic arthritis and risk of gout in US men and women , 2014, Annals of the rheumatic diseases.

[7]  J. Coresh,et al.  Racial differences in gout incidence in a population-based cohort: Atherosclerosis Risk in Communities Study. , 2014, American journal of epidemiology.

[8]  T. Funahashi,et al.  Uric Acid Secretion from Adipose Tissue and Its Increase in Obesity* , 2013, The Journal of Biological Chemistry.

[9]  L. Misery,et al.  Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[10]  M. Carroll,et al.  THE RELATIONSHIP OF TWO XANTHINE OXIDASE SINGLE NUCLEOTIDE POLYMORPHISMS TO HYPERURICEMIA, GOUT, AND DOSE OF XANTHINE OXIDASE INHIBITOR , 2013 .

[11]  F. Perez-Ruiz,et al.  Serum uric acid and metabolic risk , 2013, Current medical research and opinion.

[12]  A. Armstrong,et al.  The association between psoriasis and obesity: a systematic review and meta-analysis of observational studies , 2012, Nutrition & Diabetes.

[13]  Charles King,et al.  2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia , 2012, Arthritis care & research.

[14]  C. Pineda,et al.  Gout mimicking psoriatic arthritis flare. , 2012, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[15]  J. Wallach.  Wallach's Interpretation of Diagnostic Tests , 2012 .

[16]  D. Pašalić,et al.  Uric acid as one of the important factors in multifactorial disorders – facts and controversies , 2012, Biochemia medica.

[17]  H. Kwon,et al.  Cross‐sectional study on the correlation of serum uric acid with disease severity in Korean patients with psoriasis , 2011, Clinical and experimental dermatology.

[18]  Vinod Chandran,et al.  Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis. , 2010, Journal of autoimmunity.

[19]  K. Koike,et al.  Changes in Waist Circumference and Body Mass Index in Relation to Changes in Serum Uric Acid in Japanese Individuals , 2010, The Journal of Rheumatology.

[20]  M. Cirillo,et al.  Estimating glomerular filtration rate: Cockcroft-Gault and Modification of Diet in Renal Disease formulas compared to renal inulin clearance. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[21]  Y. Pan,et al.  An epidemiological survey of low back pain and axial spondyloarthritis in a Chinese Han population , 2009, Scandinavian journal of rheumatology.

[22]  A. Burden,et al.  Treatment of severe psoriasis with infliximab , 2008, Therapeutics and clinical risk management.

[23]  J. Roberts,et al.  Uric acid as a pathogenic factor in preeclampsia. , 2008, Placenta.

[24]  S. Bandinelli,et al.  Uric acid and inflammatory markers. , 2006, European heart journal.

[25]  T. Ogihara,et al.  Serum Uric Acid and Plasma Norepinephrine Concentrations Predict Subsequent Weight Gain and Blood Pressure Elevation , 2003, Hypertension.

[26]  M. Ingelman-Sundberg,et al.  Xanthine oxidase activity is influenced by environmental factors in Ethiopians , 2003, European Journal of Clinical Pharmacology.

[27]  I. Bruce,et al.  Hyperuricemia in Psoriatic Arthritis Prevalence and Associated Features , 2000, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.

[28]  A. R. Frisancho.  Physical Status: The Use and Interpretation of Anthropometry , 1996, The American Journal of Clinical Nutrition.

[29]  B. Agwu,et al.  Hyperuricemia in Nigerian Psoriatic Patients , 2016 .

[30]  Y. Leung,et al.  Psoriatic arthritis in Hong Kong. , 2007 .